No Data
No Data
Antisense & RNAi Therapeutics Market Report 2024, Featuring Profiles of Alnylam Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma, GSK, Ionis Pharmaceuticals, Sanofi, Sarepta Therapeutics & More - ResearchAndMarkets.com
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why
Benitec Biopharma Price Target Maintained With a $17.00/Share by Guggenheim
Benitec Biopharma Analyst Ratings
Benitec Biopharma to Participate in Upcoming Investor Conferences in December
Insider Purchase: Director at $BNTC (BNTC) Buys 12,430 Shares